TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05946460 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06421870 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06427941 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06427941 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05906732 — Predictive Biomarker (PRD): SGK1 mRNA
Genes: SGK1; SGK
Study NCT04684485 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04739566 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT04739566 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT05770713 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05770713 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05770713 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05770713 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04881240 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05060315 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05665062 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06459271 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT00122161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05033847 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06558656 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study NCT04573231 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04573231 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05180110 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05167500 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05167500 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06388122 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04589845 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT04589845 — Predictive Biomarker (PRD): CBR1 mRNA
Genes: CBR1; CBR; CRN; SDR21C1
Study NCT04589845 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT04589845 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06116916 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06116916 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05254301 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05396859 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05527223 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT06228963 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05371392 — Predictive Biomarker (PRD): ITGA4 mRNA
Genes: ITGA4; CD49D
Study NCT06035107 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06378242 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04971226 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04971226 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04186260 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT05668520 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT06532747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06532747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05552053 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06144385 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05075798 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06021119 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05126758 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT05126758 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06278077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06560242 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT04958070 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04828031 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06770478 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05020652 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05020652 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT06780839 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05848245 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05975697 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06358053 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06781047 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04960579 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04378634 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04378634 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT05479487 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05855577 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05514522 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06268353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study NCT05442060 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05123222 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05238181 — Predictive Biomarker (PRD): TFF2 mRNA
Genes: TFF2; SML1
Study NCT05631574 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05133817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06781801 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04699188 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04492553 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05657145 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05824325 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06147596 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06147596 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05804864 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05089110 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04904120 — Predictive Biomarker (PRD): MC1R mRNA
Genes: MC1R; MSHR
Study NCT00006193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04818892 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06118918 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05137509 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06037317 — Predictive Biomarker (PRD): LTK mRNA
Genes: LTK; TYK1
Study NCT05203939 — Predictive Biomarker (PRD): NR2E3 mRNA
Genes: NR2E3; PNR; RNR
Study NCT05203939 — Predictive Biomarker (PRD): CEP290 mRNA
Genes: CEP290; BBS14; KIAA0373; NPHP6
Study NCT06567561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05898737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00152685 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05776303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06223763 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05316428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05926570 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT04789642 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05134220 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04777981 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04761861 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04761861 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05748535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05914857 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04849598 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05132985 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06208124 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05632874 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05608941 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06138639 — Predictive Biomarker (PRD): SGTA mRNA
Genes: SGTA; SGT; SGT1
Study NCT06280183 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05596435 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05596435 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04841317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06196515 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05333809 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03906331 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05705180 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT04686305 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04686305 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06176989 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04543357 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05327608 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05516056 — Predictive Biomarker (PRD): CHUK mRNA
Genes: CHUK; IKKA; TCF16
Study NCT06302270 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05549934 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study NCT06536647 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06535828 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06535828 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05662865 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05255874 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06510998 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05596968 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05162664 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06359847 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT06359847 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06359847 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT06359847 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT06359847 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT06359847 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04910425 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05225948 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05326386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05834803 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05343325 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05379647 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05381688 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT05365178 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05365178 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04101292 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04101292 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00520143 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT06093932 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05968144 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06446934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04776330 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05601674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04743739 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04682899 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05945030 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05945030 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06215976 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06562491 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06562491 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06102434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06697990 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05884190 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05200663 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT05200663 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05200663 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06062277 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06778863 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06778863 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06151691 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04561492 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06781476 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06781476 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06781476 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT06780930 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06780930 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06780670 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06118047 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04915053 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04915053 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06202794 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05030363 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT05030363 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06732674 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05221229 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04760704 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04760704 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04760704 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05289674 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05289674 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT06515054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06291116 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT06291116 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT06291116 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05150691 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05096390 — Predictive Biomarker (PRD): PRCC mRNA
Genes: PRCC; TPRC
Study NCT04816253 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05087745 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05235386 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05310591 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05636319 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05242705 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05242705 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04826718 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05275998 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04724941 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06307639 — Predictive Biomarker (PRD): ACRV1 mRNA
Genes: ACRV1
Study NCT04913285 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05861999 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT05120960 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05120960 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05120960 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05558501 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05262985 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT05907733 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05907733 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT05907733 — Safety Biomarker (SAF): BDNF
Study NCT05539339 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06017635 — Predictive Biomarker (PRD): ABCC8 mRNA
Genes: ABCC8; HRINS; SUR; SUR1
Study NCT06017635 — Predictive Biomarker (PRD): TRPM4 mRNA
Genes: TRPM4; LTRPC4
Study NCT06509568 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06330376 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT06330376 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05672836 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04364126 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04685070 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05558787 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT05257551 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06282874 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06504875 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06038253 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05912062 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05277363 — Predictive Biomarker (PRD): SURF1 mRNA
Genes: SURF1; SURF-1
Study NCT04766450 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT04766450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06380816 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT06178120 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT06544941 — Predictive Biomarker (PRD): TTC9B mRNA
Genes: TTC9B
Study NCT06544941 — Predictive Biomarker (PRD): HP1BP3 mRNA
Genes: HP1BP3
Study NCT06220097 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04774705 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04774705 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05523986 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05664919 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05703438 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04747535 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04852978 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06126263 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT05914428 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT06559670 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06559670 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study NCT06559670 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05286047 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT05286047 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT05286047 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05286047 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT05422391 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06561009 — Predictive Biomarker (PRD): TNFRSF13C mRNA
Genes: TNFRSF13C; BAFFR; BR3
Study NCT05486884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05072990 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05072990 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05700708 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05700708 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05291039 — Predictive Biomarker (PRD): TREM1 mRNA
Genes: TREM1
Study NCT05653180 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05044364 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06544902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06480669 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05498857 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05556005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04716595 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05510830 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05269901 — Predictive Biomarker (PRD): GPX4 mRNA
Genes: GPX4
Study NCT05269901 — Predictive Biomarker (PRD): CA1 mRNA
Genes: CA1